Data / Drug companies / Apicore Pharmaceuticals Private Limited
Apicore Pharmaceuticals Private Limited: 64 products in the FDA NDC directory, labeler code 42973
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Apicore Pharmaceuticals Private Limited (labeler code 42973) lists 64 products in the FDA National Drug Code Directory. By type: 64 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 14, 2026.
The request: Watch Apicore Pharmaceuticals Private Limited (FDA labeler code 42973): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42973
- Products in commercial distribution
- 64
- Packages
- 119
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- November 1, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 62 | 96.9% |
| Bulk ingredients for compounding | 2 | 3.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 64 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 61 | 95.3% |
| Injection, powder, lyophilized, for solution | 1 | 1.6% |
| Injection, powder, for solution | 1 | 1.6% |
| Injection, solution | 1 | 1.6% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ferric carboxymaltose | 42973-434 | Powder | Bulk ingredients | March 14, 2026 |
| Selegiline | 42973-408 | Powder | Bulk ingredients | August 6, 2025 |
| Vosoritide | 42973-398 | Powder | Bulk ingredients | August 6, 2025 |
| Maralixibat chloride | 42973-381 | Powder | Bulk ingredients | August 6, 2025 |
| Belzutifan | 42973-376 | Powder | Bulk ingredients | August 6, 2025 |
| Betamethasone acetate | 42973-416 | Powder | Bulk ingredients | July 22, 2025 |
| Bexarotene | 42973-420 | Powder | Bulk ingredients | June 10, 2025 |
| Setmelanotide acetate | 42973-415 | Powder | Bulk ingredients | April 28, 2025 |
| Phentolamine mesylate | 42973-423 | Powder | Bulk ingredients for compounding | March 14, 2025 |
| Busulfan | 42973-392 | Powder | Bulk ingredients | November 22, 2024 |
| Carfilzomib | 42973-205 | Powder | Bulk ingredients | November 16, 2024 |
| Ferric derisomaltose | 42973-385 | Powder | Bulk ingredients | August 22, 2024 |
| Semaglutide | 42973-397 | Powder | Bulk ingredients | June 11, 2024 |
| Tirzepatide | 42973-383 | Powder | Bulk ingredients | June 11, 2024 |
| Sugammadex sodium | 42973-394 | Powder | Bulk ingredients | May 29, 2024 |
| Phentolamine mesylate | 42973-389 | Injection, powder, for solution | Bulk ingredients | April 12, 2024 |
| Cevimeline hydrochloride | 42973-395 | Injection, solution | Bulk ingredients | February 22, 2024 |
| Pentosan polysulfate sodim | 42973-367 | Powder | Bulk ingredients | January 29, 2024 |
| Ferric citrate | 42973-374 | Powder | Bulk ingredients | December 27, 2023 |
| Lurbinectedin | 42973-353 | Injection, powder, lyophilized, for solution | Bulk ingredients for compounding | May 30, 2023 |
| Ferric maltol | 42973-352 | Powder | Bulk ingredients | August 5, 2022 |
| Ferumoxytol | 42973-331 | Powder | Bulk ingredients | April 1, 2022 |
| Degarelix acetate mannitol | 42973-344 | Powder | Bulk ingredients | January 1, 2022 |
| Degarelix acetate mannitol | 42973-343 | Powder | Bulk ingredients | January 1, 2022 |
| Ganirelix acetate | 42973-325 | Powder | Bulk ingredients | October 11, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.